Goodman, A. M., Castro, A., Pyke, R. M., Okamura, R., Kato, S., Riviere, P., . . . Kurzrock, R. (2020). MHC-I genotype and tumor mutational burden predict response to immunotherapy. Genome Medicine, 12(1), 1. https://doi.org/10.1186/s13073-020-00743-4
Chicago Style (17th ed.) CitationGoodman, Aaron M., et al. "MHC-I Genotype and Tumor Mutational Burden Predict Response to Immunotherapy." Genome Medicine 12, no. 1 (2020): 1. https://doi.org/10.1186/s13073-020-00743-4.
MLA (9th ed.) CitationGoodman, Aaron M., et al. "MHC-I Genotype and Tumor Mutational Burden Predict Response to Immunotherapy." Genome Medicine, vol. 12, no. 1, 2020, p. 1, https://doi.org/10.1186/s13073-020-00743-4.
Warning: These citations may not always be 100% accurate.